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ABSTRACT In this study we assessed whether widely
accepted risk factors for atherosclerotic vascular dis-
eases such as lipoprotein(a) [Lp(a)], a cholesterol-rich
lipoprotein under strict genetical control, and other lipid
parameters change with age. The variations of blood lev-
els and the pathophysiological role of Lp(a) in old peo-
ple, and particularly in the oldest old, are unknown.
Accordingly, we measured Lp(a) levels as well as total,
LDL, and HDL cholesterol (CT), and triglycerides (TG)
in sera from 75 healthy centenarians, 114 randomly se-
lected subjects under 65 years, 73 randomly selected el-
derly people, and 30 healthy selected elderly people.
The results showed that Lp(a) serum levels did not vary
by age group, including centenarians. Remarkably, one-
quarter of the centenarians had high Lp(a) serum levels
even though they never suffered from atherosclerosis-
related diseases. At variance with young and aged peo-
ple, centenarians with high Lp(a) serum levels also had
high plasma concentrations of the proinflammatory cy-
tokine IL-6, suggesting that genetic control of the Lp(a)
serum level may attenuate with age and that environ-
mental factors such as chronic subclinical inflammatory
processes may play a role. We also showed that most
centenarians are paradoxically characterized by low
HDL-CT and relatively high TG levels, which together
are considered to be strong risk factors for coronary
heart disease. On the whole, these data support the hy-
pothesis that a continuous and complex reshaping of
lipid metabolism occurs in physiological aging, likely
contributing to successful aging.—Baggio, G., Donaz-
zan, S., Monti, D., Mari, D., Martini, S., Gabelli, C., Dalla
Vestra, M., Previato, L., Guido, M., Pigozzo, S., Cortella,
I., Crepaldi, G., Franceschi, C. Lipoprotein(a) and lipo-
protein profile in healthy centenarians: a reappraisal of
vascular risk factors. FASEB J. 12, 433–437 (1998)
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HIGH LEVELS OF total serum cholesterol (CT),3 low
density lipoprotein (LDL)-CT, and triglycerides (TG)
as well as low levels of high density lipoprotein
(HDL)-CT are well-recognized risk factors for cardio-
vascular disease (1, 2). Recently, lipoprotein(a)
[Lp(a)], a genetically controlled cholesterol-rich li-
poprotein whose biological role is still unknown (3),
has been suggested by numerous studies as an inde-
pendent risk factor for premature coronary heart dis-
ease, stroke, restenosis of vein grafts after coronary
bypass surgery, and peripheral artery disease (4–5);
Lp(a) is present in atherosclerotic plaques and stim-
ulates smooth muscle cell replication (6). Although
individual Lp(a) levels appear to remain remarkably
stable, in some pathophysiological states it can be-
have as an acute-phase protein (7); increased Lp(a)
levels have also been found in chronic inflammatory
disorders such as rheumatoid arthritis (5). Few and
contrasting data have been published about Lp(a)
levels and its atherogenic effect in the elderly (8–10).
The aim of this study was to verify whether the pre-
viously mentioned, widely accepted and well-studied
lipid risk factors for atherosclerosis and atheroscle-
rosis-related diseases change with age. Accordingly,
lipoprotein (a) [Lp(a)] levels as well as the lipopro-
tein profile (total, LDL, and HDL cholesterol) were
studied in serum samples from 75 centenarians care-
fully selected for their health status compared with
217 control subjects of different ages, selected either
randomly or according to their good health status.
The main and unexpected findings were: 1) Lp(a)
serum levels did not vary in the different ages, in-
cluding centenarians; 2) 25% of the centenerians
had high levels of Lp(a); 3) only centenarians (but
not young and aged subjects) with high Lp(a) levels
had a significantly high serum level of proinflam-
matory cytokine IL-6; 4) in centenarians, total and
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LDL cholesterol levels were similar to those found in
young controls, but significantly lower than those
found in randomly selected or healthy elderly,
whereas HDL cholesterol was lower and triglycerides
higher than in young subjects. As far as we know,
these are the first data about lipid parameters in cen-
tenarians, and they suggest that the biological signif-
icance of vascular risk factors may change with
advanced age.
METHODOLOGY
Blood was drawn after 12 h of fasting from four groups of
subjects living in Northern Italy; group 1: 75 healthy cente-
narians (14 males and 61 females) aged 100–106 years ( V1{
100.9{1.4); group 2: 114 randomly selected subjects underSD:
65 years (39 males and 75 females) aged 8–64 years ( V1{SD:
35.8{11.8); group 3: 73 randomly selected elderly persons (16
males and 57 females) aged 65–98 years 83.5{7.6);( V1{SD:
group 4: 30 healthy selected elderly (6 males and 24 females)
aged 61–80 years 71.4{5.5). Group 1 was selected( V1{SD:
according to clinical, biochemical, and hematological criteria
and parameters as previously reported (11); part of this group
has been studied for other parameters (12). Group 2 included
randomly selected volunteers working in the General Hospi-
tal, University of Padua, Italy. These subjects were clinically
healthy and attending work (students, medical doctors,
nurses, technicians). Group 3 included randomly selected, ap-
parently healthy, old volunteers, about half of them living in
institutions for the elderly in Padua city. According to the ran-
dom selection criteria, no biochemical or hematological anal-
ysis was performed in groups 2 and 3 to check their healthy
status and no questionnaire for medications was used. Group
4 included old volunteers carefully selected according to the
SENIEUR Protocol proposed by Ligthart et al. (13). At the
onset, a population of 300 subjects living in Carpi (Modena,
Italy), participating in a large study of the health status at a
population level, was analyzed for clinical health, several bio-
chemical and hematological parameters, and medications. Ac-
cording to the strict exclusion and inclusion criteria, only 30
subjects were eventually enrolled. All subjects in groups 1–4
were Caucasian and lived in Northern Italy.
Lp(a) levels were measured in serum by a noncompetitive
sandwich enzyme-linked immunoassay (ELISA) method (14);
total cholesterol (15), HDL cholesterol (after polyanion pre-
cipitation) (16), and triglycerides (17) were measured man-
ually by standard enzymatic methods, LDL cholesterol was
calculated by the Friedewald formula. Tumor necrosis factor-a
(TNF-a) and interleukin 6 (IL-6) were measured in plasma
with commercially available ELISA (18).
Statistical analysis
Lp(a) levels were compared between the groups by the non-
parametric Wilcoxon ranked sum test because of the well-
known skewed distribution of the concentration of this
lipoprotein in Caucasians; the Student’s t test was used to com-
pare lipids, cytokines, and Lp(a) logarithms. The correlation
of Lp(a) levels with age was evaluated with simple linear re-
gression analysis.
RESULTS
Table 1 shows that no statistically significant age-re-
lated differences in Lp(a) serum concentration were
found among the four groups, including centenari-
ans. Indeed, no significant correlations were found
between Lp(a) and age when subjects of all four
groups were analyzed together. The same result was
obtained when centenarians were excluded from the
analysis (data not shown). In centenarians, the serum
concentration of Lp(a) varied widely among individ-
uals as well as in the three control groups considered
here. Moreover, the percent of frequency of subjects
with Lp(a) levels below and above 30 mg/dl, the con-
ventional limit of high-risk levels (3), was similar in
the four groups. In particular, 25.3% of healthy cen-
tenarians had Lp(a) levels higher than 30 mg/dl. To
identify the possible reason (or reasons) for this un-
expected high level of Lp(a) in healthy centenarians,
we measured the plasma level of proinflammatory cy-
tokines such as IL-6 and TNF-a, which are capable of
increasing the plasma level of acute-phase proteins.
These measurements were performed in the cente-
narians (group 1), young subjects (group 2), and old
people belonging to group 3 (randomly selected) or
4 (selected for healthy status) who had Lp(a) levels
higher than 50 mg/dl or lower than 10 mg/dl.
Table 2 shows that significantly higher levels of IL-
6, but not of TNF-a, were present only in centenari-
ans with high Lp(a) levels. This increase in IL-6 was
not present either in young (group 2) or old subjects
(groups 3 and 4) with similar high Lp(a) serum con-
centrations. A marked increase in the IL-6 serum
level was found in randomly selected elderly (group
3) compared with healthy selected old people (group
4). This difference in the serum IL-6 level was also
evident when all people belonging to these two
groups were analyzed (10.3{0.7 pg/ml vs. 1.8{0.3
pg/ml in 65 subjects of group 3 and 29 subjects of
group 4, respectively, P0.0001).
Serum lipid and lipoprotein levels were measured
in healthy centenarians as well as in the other three
groups considered in this study (Table 3). Healthy
centenarians showed: 1) total and LDL cholesterol
levels similar to young subjects, but significantly lower
than in randomly or healthy selected elderly; 2) HDL
cholesterol values similar to randomly selected el-
derly, but significantly lower than in young subjects;
and 3) triglyceride levels significantly higher than
those found in young people, but similar to elderly
subjects.
DISCUSSION
Several studies indicate that altered serum lipid and
lipoprotein levels can be considered important risk
factors for atherosclerotic vascular diseases (1, 2). In
particular, high levels of LDL-CT and low levels of
HDL-CT have been described in patients who suffer
coronary heart disease (19). More recently, high lev-
els of Lp(a) have been considered an independent
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Age range (in years) 100–106 8–64 65–98 61–80
Age mean 100.9 { 1.4 35.8 { 11.8 83.5 { 7.6 71.4 { 5.5
Lp(a) average 22.4 19.3 23.8 23.0
Lp(a) median 17.2 12.5 15.2 14.2
Lp(a) range 1–76 1–90 1–137 1–123
Log Lp(a)( V1{SD) 1.11 { 0.52 1.06 { 0.48 1.13 { 0.51 1.12 { 0.51
% subjects with
Lp(a) 30 mg/dl 25.3 22.8 23.3 23.3
Lp(a) 30 mg/dl 74.7 77.2 76.7 76.7
risk factor for atherosclerotic vascular diseases (4–5).
The serum level of this lipoprotein is apparently un-
der strict genetic control and shows a poor response
to hypolipidemic diet and/or drugs (3, 20). Thus, it
could be expected that healthy elderly, and particu-
larly healthy centenarians (people who escaped ma-
jor age-related diseases, including vascular accidents
such as stroke and myocardial infarction), had low
levels of Lp(a) as well as a favorable lipoprotein pat-
tern. Moreover, as it is known that all atherosclerotic
vascular diseases increase with age (21), it could be
expected that serum levels of Lp(a) also change with
age. These predictions were only partially fulfilled.
First, the median and mean log of serum Lp(a)
levels did not change with age (Table 1). Second, a
quarter of healthy centenarians had Lp(a) levels con-
sidered to put them at risk for atherosclerosis and
related complications. This paradoxical finding ap-
parently challenges the tenet that high levels of Lp(a)
are an independent risk factor for the above-men-
tioned diseases. To fully evaluate these data, we
should know whether this portion of centenarians
(25%) were characterized for their entire life by such
high levels of Lp(a). This question remains unan-
swered until longitudinal studies are performed. This
finding in healthy centenarians who suffered no vas-
cular disease in their long life suggests either that
Lp(a) is not a risk factor in the oldest-old or that it is
counteracted by unknown protective factors whose
identification would be of great interest. Alterna-
tively, it could be speculated that Lp(a) may have a
paradoxical protective effect that emerges only later
in life in selected people such as healthy centenari-
ans. Such phenomena are not completely unex-
pected according to one of the most accepted
theories of aging: pleiotropic antagonism (22).
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TABLE 2. Interleukin 6 and tumor necrosis factor-a plasma levels in centenarians and controls with high and low Lp(a) levels a( V1{SE)
Lp(a) (mg/dl) TNF-a (pg/ml) IL-6 (pg/ml) Age (years)
Centenarians
High Lp(a) (n8) 65.0 { 3.09 2.68 { 0.57 17.66 { 8.48* 102 { 0.93
Low Lp(a) (n12) 4.33 { 0.81 2.53 { 0.53 3.11 { 0.60 101 { 0.51
Young controls
High Lp(a) (n6) 77.8 { 14.1 1.87 { 0.35 3.87 { 0.40 33.0 { 5.02
Low Lp(a) (n6) 2.75 { 0.53 2.40 { 1.29 3.10 { 0.28 35.0 { 2.53
65 years, randomly selected
High Lp(a) (n9) 77.4 { 10.01 n.d. 9.75 { 2.01 84.3 { 3.00
Low Lp(a) (n26) 4.99 { 0.58 n.d. 9.75 { 1.23 84.6 { 1.56
65 years, healthy selected
High Lp(a) (n4) 77.2 { 16.53 n.d. 3.43 { 2.06 71.0 { 3.03
Low Lp(a) (n12) 6.13 { 0.97 n.d. 1.25 { 0.11 71.8 { 1.25
a P  0.05 vs. centenarians with low Lp(a); n.d.  not determinated.











CT 189.8 { 34.9•# 195.9 { 29.8 228.1 { 45.1 223.3 { 33.2
LDL-CT 115.1 { 27.8• 117.0 { 26.3 145.5 { 37.1 n.d.
HDL-CT 49.2 { 12.97* 62.2 { 14.8 54.8 { 16.5 n.d.
TG 125.3 { 65.0* 86.1 { 32.4 139.0 { 59.6 112.8 { 48.6
• P  0.001 vs. 65 yrs randomly selected. 7 P  0.05 vs. 65 yrs randomly selected. # P  0.001 vs.
60 yrs healthy selected. * P  0.001 vs. 65 yrs randomly selected.
Another tenet challenged by our data is that Lp(a)
is mostly or strictly under genetic control and that
environmental influences play a negligible role. On
the contrary, the high level of IL-6 only in centenar-
ians with high Lp(a) serum levels, but not in young
and aged subjects, suggests that genetic control of the
serum level of Lp(a) may attenuate with advanced
age where environmental factors, such as chronic
subclinical inflammatory process, may be involved
(5, 23).
The increased number of activated T cells de-
scribed in the peripheral blood of centenarians fits
this interpretation (11). Moreover, an increase in the
production of proinflammatory cytokines, particu-
larly IL-6, occurs with age (18, 24), and includes cen-
tenarians (unpublished data). Accordingly, Lp(a)
could behave as an acute-phase protein, such as fi-
brinogen, which also showed a paradoxical increase
in healthy centenarians (25).
Another interesting result from this study is the
marked difference concerning IL-6 serum levels in
randomly selected vs. strictly selected healthy elderly.
Indeed, high levels of IL-6 were found in the ran-
domly selected elderly persons, a group that likely
includes the most subjects with subclinical diseases.
Low serum levels of IL-6 appear to be a reliable
marker of healthy status; conversely, high levels of
this cytokine can be considered a potent risk factor
in the elderly. This finding is in accord with recent
data suggesting that high levels of IL-6 are predictors
of morbidity in longitudinal studies of cohorts of el-
derly people (26). From this point of view, the oc-
currence of healthy centenarians with high levels of
IL-6 is another paradox to be added to the increasing
list of risk factors that apparently change their bio-
logical significance in centenarians (12, 25).
This finding regarding the serum level of Lp(a) in
centenarians occurs concomitantly with other inter-
esting changes in serum levels of other major lipids
and lipoproteins. Indeed, most centenarians were
also characterized by low HDL cholesterol and rela-
tively high triglycerides, two parameters together
considered a very strong risk factor for coronary
heart disease. On the whole, the levels of plasma lip-
ids and lipoproteins in centenarians apparently are a
mixture of characteristics considered either favorable
(low total and LDL CT) or unfavorable (low HDL-
CT and high TG) for atherosclerosis in young
people.
Our data seem to suggest that the physiological and
pathological roles of Lp(a) likely change with age de-
spite the relatively stable serum levels of this lipopro-
tein throughout the entire human life span. These
data also support the hypothesis that a continuous
reshaping in lipid physiology occurs with age and is
likely a critical factor for survival and successful aging.
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A major consequence of this reshaping is that
changes in the serum level of protein, lipids, and li-
poproteins that are considered risk factors for ath-
erosclerotic vascular diseases in young people may
lose their biological significance and assume a differ-
ent, unknown role with advanced age. Such a re-
shaping can have far-reaching consequences for
laboratory standard values and, when possible, in
therapeutic intervention for the elderly. The results
presented here are in line with our general hypoth-
esis that a continuous remodeling develops with time
as a result of the continuous adaptation to changes
occurring in the body with age in response to internal
and external damaging agents (27).
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